SHANGHAI/LONDON (Reuters) - China fined GlaxoSmithKline Plc a record 3 billion yuan ($489 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drugmaker.
SHANGHAI, Sept 19 (Reuters) - Mark Reilly, the former China head of British drugmaker GlaxoSmithKline PLC , will be deported from China and will not face jail time in the country, according to a source with direct knowledge of the matter.
BEIJING, Sept 19 (Reuters) - China has fined British pharmaceuticals giant GlaxoSmithKline Plc 3 billion yuan ($488.8 million) for paying out bribes in what is a record penalty for China, state news agency Xinhua said on Friday.
good value to long term investors. Introducing first: from United Kingdom representing the Healthcare sector, GlaxoSmithKline PLC (NYSE: GSK ). Current Situation : Whichever way you see it, the stock has taken a hammering. It's down
SHANGHAI/WASHINGTON (Reuters) - A U.S. anti-bribery probe into GlaxoSmithKline Plc touched on the firm's Chinese consumer healthcare business in 2012, internal documents show, suggesting the drugmaker's compliance
MUMBAI, Sept 1 (Reuters) - India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc 's Advair, a move that will further dent sales of the British firm's top-selling product.
Even though device patents may hold off generic Advair competition until 2016, these patents are weaker than composition-of-matter patents, which opens the door to generics in the near term, especially in Europe, where regulators seems more willing to approve generic inhaled drugs.Pricing pressure
SHANGHAI (Reuters) - A British investigator and his American wife will stand trial in Shanghai on Friday in a case that is seen as key to a bribery investigation against GlaxoSmithKline Plc and has unnerved the growing community of corporate sleuths in China.
SHANGHAI, Aug 8 (Reuters) - A British investigator and his American wife will stand trial in Shanghai on Friday in a case that is seen as key to a bribery investigation against GlaxoSmithKline Plc and has unnerved the growing community of corporate sleuths in China.
Sept 18 (Reuters) - ChemoCentryx Inc said partner GlaxoSmithKline Plc returned the rights to its inflammatory bowel disease drug, the company's lead product candidate.